Equine HABP antibody and antigen (recombinant protein)
Diagnostic anti-Equine HABP antibodies pairs and antigen for animal health (animal Equine/Horse rheumatoid arthritis (RA) andosteoarthritis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-HABP-Ag01 | Recombinant Equine HABP protein | 3090 |
GMP-EQU-HABP-Ab01 | Anti-Equine HABP mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-HABP-Ab02 | Anti-Equine HABP mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-HABP-Ab03 | Anti-Equine HABP human monoclonal antibody (mAb) | 1953 |
GMP-EQU-HABP-Ab04 | Anti-Equine HABP human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-EQU-HABP-Ag01 |
Product Name | Recombinant Equine HABP protein |
Target/Biomarker | Equine Hyaluronic acid binding protein (HABP) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine Hyaluronic acid binding protein antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HABP level test of animal Equine/Horse with rheumatoid arthritis (RA) andosteoarthritis. |
Tag | His |
Products description | Recombinant Equine HABP protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-HABP-Ab01, GMP-EQU-HABP-Ab02 |
Product Name | Anti-Equine HABP mouse monoclonal antibody (mAb) |
Target/Biomarker | Equine Hyaluronic acid binding protein (HABP) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine Hyaluronic acid binding protein antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-HABP antibodies in HABP level test of animal Equine/Horse with rheumatoid arthritis (RA) andosteoarthritis. |
Tag | mFc |
Products description | Anti-Equine HABP mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-HABP antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-HABP-Ab03, GMP-EQU-HABP-Ab04 |
Product Name | Anti-Equine HABP human monoclonal antibody (mAb) |
Target/Biomarker | Equine Hyaluronic acid binding protein (HABP) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Equine Hyaluronic acid binding protein antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-HABP antibodies in HABP level test of animal Equine/Horse with rheumatoid arthritis (RA) andosteoarthritis. |
Tag | hFc |
Products description | Anti-Equine HABP human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-HABP antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Equine Hyaluronic Acid-Binding Protein (eHABP) emerges as a fundamental player in the intricate world of equine physiology. This glycoprotein, encoded by the eHABP gene, specializes in the orchestration of hyaluronic acid (HA), a prominent constituent of the extracellular matrix. HA's primary role is to maintain tissue hydration, lubrication, and resilience, and eHABP is its faithful guardian in the equine body. HA, a high molecular weight polysaccharide, resides in various tissues in horses, including connective tissues, skin, and synovial fluid. Its biophysical properties make it a vital component for proper joint function and overall tissue health. However, HA is prone to degradation and requires constant vigilance to maintain its integrity. This is where eHABP steps in. eHABP forms tight bonds with HA molecules, effectively shielding them from enzymatic degradation and environmental factors. The significance of eHABP becomes particularly evident in the context of joint health. In synovial joints, HA acts as a natural lubricant, facilitating smooth articulation and reducing friction during movement. Without adequate HA levels and efficient HA-binding proteins like eHABP, joints may become susceptible to wear and tear, leading to conditions like osteoarthritis, a painful and debilitating ailment in horses. Moreover, eHABP's role extends beyond joint health. It contributes to tissue hydration, ensuring that connective tissues remain pliable and resilient. In doing so, it supports overall tissue integrity, wound healing, and the body's ability to withstand mechanical stress. Furthermore, eHABP interacts with other proteins and participates in various signaling pathways, influencing processes like tissue repair and inflammation.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.